GetTopicDetailResponse(id=5b19100269bb, topicName=預(yù)警, introduction=預(yù)警, content=null, image=null, comments=1, allHits=1161, url=https://h5.medsci.cn/topic?id=100269, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=1158, tagList=[TagDto(tagId=1158, tagName=預(yù)警)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1196308, encodeId=2ca0119630871, content=看了評(píng)論區(qū)，發(fā)現(xiàn)FO真的很火，周圍的同學(xué)也是人手一篇。昨晚看了一下FO的2021發(fā)文已超過6000篇，2022年1.1至今的發(fā)文量是2021年同一時(shí)期的兩倍。大家真的要謹(jǐn)慎呀！上次人手一篇的雜志是scientific reports和oncotarget。兩個(gè)雜志的下場(chǎng)都蠻慘的。<a href='/topic/show?id=5b19100269bb' target=_blank style='color:#2F92EE;'>#預(yù)警#</a>, objectTitle=FRONT ONCOL, objectType=tool_impact_factor, longId=13340, objectId=a9fc13340, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/journal/cover/2021/EOx_202109271315057970.jpg, objectUrl=/sci/submit.do?id=a9fc13340, replyNumber=1, likeNumber=105, createdTime=2022-02-23, rootId=0, userName=胸外科小辣雞, userId=75b92509278, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9fc13340, moduleTitle=FRONT ONCOL, moduleType=tool_impact_factor, hrefUrl=http://ermita.cn/sci/submit.do?id=a9fc13340)], followStatus=false, userIsMember=false, type=1, lengthMark=1)]
梅斯話題小助手
2020-05-29
前往app查看評(píng)論內(nèi)容
看了評(píng)論區(qū)，發(fā)現(xiàn)FO真的很火，周圍的同學(xué)也是人手一篇。昨晚看了一下FO的2021發(fā)文已超過6000篇，2022年1.1至今的發(fā)文量是2021年同一時(shí)期的兩倍。大家真的要謹(jǐn)慎呀！上次人手一篇的雜志是scientific reports和oncotarget。兩個(gè)雜志的下場(chǎng)都蠻慘的。#預(yù)警#
